Skip to content
DataLookout
Menu

NCT03753204

Salt-Sensitivity and Immunity Cell Activation

StatusCompleted
PhasePhase 1/2
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 14 versions: 11 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 15 words
    • Trial completed
    • Final enrollment: 36 participants (planned 20)
    • Publications: details revised at 2 of 2 entries
  2. Notable Primary completion date: Sep 1, 2025 to Sep 1, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Sep 15, 2025 to Sep 15, 2026
    • Site details revised
    v13
  3. Minor Start date changed from estimate of Sep 2021 to Sep 1, 2021v9
  4. Notable Primary completion date: Sep 1, 2021 to Sep 1, 2025
    • Study completion date: Sep 15, 2021 to Sep 15, 2025
    v8
  5. Notable Start date: Apr 2021 to Sep 2021v7
Show 5 earlier versionsHide 5 earlier versions
  1. Notable Start date: Jan 2021 to Apr 2021v6
  2. Notable Start date: Nov 2020 to Jan 2021v5
  3. Notable Start date: Sep 1, 2020 to Nov 2020v4
  4. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Mar 1, 2020 to Sep 1, 2021
    • Start date: Mar 2020 to Sep 1, 2020
    • Study completion date: Mar 15, 2020 to Sep 15, 2021
    • Site details revised
  5. Notable Start date: Mar 1, 2019 to Mar 2020v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

The percent of participants with salt sensitive blood pressure
Timeframe: Over 3 days

Secondary (1)

Percent of participants with immune cell activation

Arms and interventions

Weinberger protocolExperimental

During the Weinberger protocol, salt loading will be achieved by the combination of a high-salt diet (isocaloric, 160 mEq Na and 70 mEq K), and an infusion of 2L of saline (300 mEq Na+). Patients will have free access to water but their food will be limited to that provided by the protocol. Salt depletion will be accomplished by administering an isocaloric diet containing 10 mEq Na and 70 mEq K and continued unlimited water intake. At 8 am, 12 noon and 4 pm, subjects will be given 40 mg of furosemide or lasix orally.

Drugs: Furosemide 40 mg

Sites

1 site in 1 country

  • Vanderbilt University Medical CenterNashville, Tennessee, United States